These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 29771157)
1. How to prevent diabetes-triggered heart disease. An S; Zhao B; Zhang X; Liu Q Eur J Prev Cardiol; 2018 Nov; 25(16):1789. PubMed ID: 29771157 [No Abstract] [Full Text] [Related]
2. 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps. Paneni F Diab Vasc Dis Res; 2014 Jan; 11(1):5-10. PubMed ID: 24254974 [No Abstract] [Full Text] [Related]
3. Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes. Laffin LJ; Bakris GL Diabetes Obes Metab; 2018 Jun; 20(6):1335-1336. PubMed ID: 29424470 [TBL] [Abstract][Full Text] [Related]
4. Update on Management of Type 2 Diabetes for Cardiologists. Qureshi M; Gammoh E; Shakil J; Robbins R Methodist Debakey Cardiovasc J; 2018; 14(4):273-280. PubMed ID: 30788013 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the long-term effects of high-fat v. low-fat diet consumption on cardiometabolic risk factors in subjects with abnormal glucose metabolism: a systematic review and meta-analysis. Schwingshackl L; Hoffmann G Br J Nutr; 2014 Jun; 111(12):2047-58. PubMed ID: 24666665 [TBL] [Abstract][Full Text] [Related]
6. The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes. Paty BW Can J Diabetes; 2015 Dec; 39 Suppl 5():S155-9. PubMed ID: 26654859 [TBL] [Abstract][Full Text] [Related]
7. Is Hemoglobin A1c the Right Outcome for Studies of Diabetes? Lipska KJ; Krumholz HM JAMA; 2017 Mar; 317(10):1017-1018. PubMed ID: 28125758 [No Abstract] [Full Text] [Related]
8. The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM). Basile JN J Diabetes Complications; 2013; 27(3):280-6. PubMed ID: 23375850 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Safety of Current and Emerging Glucose-Lowering Therapies. Fitchett D Can J Diabetes; 2015 Dec; 39 Suppl 5():S176-82. PubMed ID: 26654861 [No Abstract] [Full Text] [Related]
10. Following the LEADER - why this and other recent trials signal a major paradigm shift in the management of type 2 diabetes. Kosiborod M J Diabetes Complications; 2017 Feb; 31(2):517-519. PubMed ID: 27839923 [TBL] [Abstract][Full Text] [Related]
11. [The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results]. Levy JC; Cull CA; Stratton IM; Holman RR; Turner RC Journ Annu Diabetol Hotel Dieu; 1993; ():123-37. PubMed ID: 8331860 [No Abstract] [Full Text] [Related]
12. Addressing cardiovascular risk in patients with type 2 diabetes: focus on primary care. Stolar M Am J Med Sci; 2011 Feb; 341(2):132-40. PubMed ID: 20818229 [TBL] [Abstract][Full Text] [Related]
14. Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients. De Feyter HM; Praet SF; van den Broek NM; Kuipers H; Stehouwer CD; Nicolay K; Prompers JJ; van Loon LJ Diabetes Care; 2007 Oct; 30(10):2511-3. PubMed ID: 17626892 [No Abstract] [Full Text] [Related]
15. Exercise and Beta-Glucan Consumption (Saccharomyces cerevisiae) Improve the Metabolic Profile and Reduce the Atherogenic Index in Type 2 Diabetic Rats (HFD/STZ). Andrade EF; Lima AR; Nunes IE; Orlando DR; Gondim PN; Zangeronimo MG; Alves FH; Pereira LJ Nutrients; 2016 Dec; 8(12):. PubMed ID: 27999319 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of diets high in animal or plant protein on metabolic and cardiovascular markers in type 2 diabetes: A randomized clinical trial. Sucher S; Markova M; Hornemann S; Pivovarova O; Rudovich N; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AFH Diabetes Obes Metab; 2017 Jul; 19(7):944-952. PubMed ID: 28181738 [TBL] [Abstract][Full Text] [Related]
17. Impact of Metformin on Exercise-Induced Metabolic Adaptations to Lower Type 2 Diabetes Risk. Malin SK; Braun B Exerc Sport Sci Rev; 2016 Jan; 44(1):4-11. PubMed ID: 26583801 [TBL] [Abstract][Full Text] [Related]
18. Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes. Turk HM; Buyukberber S; Sevinc A; Ak G; Ates M; Sari R; Savli H; Cigli A Diabetes Care; 2000 Jun; 23(6):864-7. PubMed ID: 10841017 [No Abstract] [Full Text] [Related]